EVs derived from UC-MSCs can effectively inhibit the proliferation and invasion of ESCs, as well as the expression of SF-1, ERβ, and aromatase, thereby restricting the growth, invasion, and estrogen levels of ectopic lesions, thus leading to the alleviation of endometriosis. Here, CYP19A1 is linked to endometriosis.